Beal Anne 4
4 · Omada Health, Inc. · Filed Jun 18, 2026
Research Summary
AI-generated summary of this filing
Omada Health Director Anne Beal Receives 10,882-Share Award
What Happened Anne Beal, a director of Omada Health, was granted 10,882 restricted stock units (RSUs) on June 16, 2026. The reported acquisition price is $0.00 (this is an equity award rather than a market purchase), so no cash changed hands in this transaction.
Key Details
- Transaction type: Award/Grant (Code A) — 10,882 RSUs granted on 2026-06-16.
- Reported price: $0.00 per share; reported aggregate cash value: $0.
- Filing date: 2026-06-18 (filed within the normal Form 4 reporting window).
- Vesting (Footnote F1): 100% of the RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting, subject to continued service.
- Shares owned after transaction: Not specified in the provided filing excerpt.
Context RSUs are compensation awards that convert into common shares upon vesting; this grant does not represent an open-market purchase or sale and should be viewed as a compensation/retention event rather than a direct bullish or bearish trading signal.
Insider Transaction Report
Form 4
Beal Anne
Director
Transactions
- Award
Common Stock
[F1]2026-06-16+10,882→ 20,618 total
Footnotes (1)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date.
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Anne Beal|2026-06-18